UT Southwestern and Komen Foundation Offer Breast Care Fellowship

Publication
Article
OncologyONCOLOGY Vol 12 No 8
Volume 12
Issue 8

The Center for Breast Care at UT Southwestern Medical Center in Dallas and the Susan G. Komen Breast Cancer Foundation have teamed up to offer a new 1-year fellowship for physicians interested in the multidisciplinary care of breast

The Center for Breast Care at UT Southwestern Medical Center in Dallas and the Susan G. Komen Breast Cancer Foundation have teamed up to offer a new 1-year fellowship for physicians interested in the multidisciplinary care of breast cancer patients.

This program was designed to provide the physician with an in-depth understanding of the entire scope of a breast-cancer patient’s treatment. It places special emphasis on refining physicians’ skills in counseling and discussing such topics as quality-of-life and end-of-life issues.

Treating the Whole Patient

"We are delighted to join the Komen Foundation and offer a fellowship that specifically addresses the needs of physicians in treating breast cancer patients comprehensively," said Dr. George Peters, executive director of the Center for Breast Care and holder of the

Marilyn R. Corrigan Distinguished Chair in Breast Cancer Surgery. "This fellowship has the potential to set a new standard for multidisciplinary breast care," said Elda Railey, director of national grants. "Through this program, the fellows will broaden their understanding of all the treatment issues faced by breast cancer patients. The program also provides education in genetics and the disease’s effects on a patient’s daily life and family. It is a comprehensive approach to training in today’s world of specialization."

Fellows will be instructed in pathology, plastic surgery, and medical oncology, radiation oncology, radiology, surgery, genetics, and psychiatry/psychology at UT Southwestern. They will also spend 1 day a month at the Komen Foundation headquarters developing their communication skills. Successful candidates must hold an md or equivalent degree and be board-eligible or board-certified in one of the above areas.

Recent Videos
Updated results from the 1b/2 ELEVATE study elucidate synergizing effects observed with elacestrant plus targeted therapies in ER+/HER2– breast cancer.
Patients with ESR1+, ER+/HER2– breast cancer resistant to chemotherapy may benefit from combination therapy with elacestrant.
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.